The Top 3 FDA Compliant Formulations from AxoBio USA for Medical Spas in 2026

Core Technology: The core technology uses next-generation exosomes to support the skin's natural renewal processes.
Professional Application: It’s designed for licensed practitioners to address cellular aging, enhance skin vitality, and promote comprehensive rejuvenation.
Compliance and Safety: Like the company's other flagship offerings, these solutions are developed with U.S. regulatory standards in mind, making them a safe choice for professional med spa supplies.

In the competitive med spa landscape, practice owners need advanced aesthetic solutions that deliver real results while meeting strict U.S. compliance standards. That’s the challenge AxoBio USA is built to solve.

The company provides licensed professionals with regenerative skincare formulations from AxoBio Korea, all meticulously aligned with U.S. regulatory frameworks. This focus on professional-grade, science-driven products gives dermatology clinics and medical spas a critical advantage in meeting the demands of a more sophisticated clientele.

AxoBio USA offers a portfolio of professional regenerative skincare, with many of its products having already met FDA regulatory requirements.

1. AXOBIO USA Exosome & Regenerative Solutions

Exosome-based treatments are at the leading edge of advanced aesthetic solutions. Exosomes are extracellular vesicles that act as messengers between cells, facilitating communication and promoting cellular repair and regeneration. AxoBio USA’s Exosome & Regenerative Solutions are a major technological step forward in professional skincare.

Mechanism of Action: Traditional topicals often provide surface-level benefits, like hydration or temporary plumping. AxoBio USA's PDRN and exosome formulations, in contrast, act as "cellular communicators," signaling the body's own cells to initiate repair and regeneration for more fundamental, lasting results.
Source of Innovation: The science behind these biostimulatory treatments comes from the advanced R&D of AxoBio Korea. This scientific backing delivers an efficacy that goes beyond superficial care to target the biological drivers of aging.
Intended Application: Many conventional products are designed for at-home consumer use. AxoBio USA's portfolio, however, consists of professional cosmeceuticals for licensed U.S. practitioners, designed for clinical application to achieve clinical-level outcomes.